Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Chemistry Analyzer Performs 9,800 Tests/Hour

By LabMedica International staff writers
Posted on 24 Aug 2011
An automated chemistry system series released in Europe is available in four different scalable models.

The AU5800 series improves processing time compared to the current AU2700 and AU5400 systems, meeting the demands of high- and ultra-high-volume clinical laboratories. More...
Specific models in the AU5800 series are available in one- to four-module configurations with the additional option of including either a single or a dual Integrated Systems Europe (ISE) flow cell.

Operators can perform simple functions, such as replacing probes, mixers, and electrodes within three steps in less than 60 seconds without tools. The AU5800 series also features an easy-to-use touch screen graphical user interface and operating software for an enhanced user experience. Other improvements include a new sample tray inlet, integrated rerun rack buffer unit, special priority rack ports for improved workflow efficiency, and three sample-processing lanes for optimized turnaround time.

Beckman Coulter’s (Brea, CA, USA) AU5800 series enables laboratories to add components as their workflow demands increase. AU5800 systems can be used as stand-alone instruments or are designed for connectivity with Beckman Coulter automation solutions, allowing for integration with the company’s clinical information systems and immunoassay testing platforms.

Throughput of the AU5800 series is up to 2,000 photometric chemistry tests per hour for the single module (AU5810). With a four-unit configuration (AU5840), laboratories can achieve throughput of up to 8,000 photometric tests per hour and can gain even more efficiency by adding a dual ISE flow cell that increases maximum throughput of up to 9,800 combined photometric/electrolyte tests per hour.

Beckman Coulter, Inc. previewed its newest high throughput chemistry analyzers, clinical information solutions, and cellular analysis systems at the 2011 American Association of Clinical Chemists (AACC)/American Society for Clinical Lab Science (ASCLS) Annual Meeting and Clinical Lab Expo (CLE). The expo was held at the Georgia World Congress Center in Atlanta (GA, USA) from July 24-28, 2011.

Related Links:

Beckman Coulter



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.